«Nanotechnology for allergy experts»
Presented by CTI Invest on 15.12.2010
Abionic is a start-up based in Switzerland, strongly positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to offer the medical profession a novel point-of-care diagnostic tool which is designed to provide patients with personal allergy profiles.
Investor: BlueOcean Ventures
|| looking for investor